| http://www.w3.org/ns/prov#value | - The difference in outcome suggests gender is an important factor in designing clinical trials, and that gender should be a stratification factor in randomized trials.In our analysis, patients with large cell carcinoma or NOS histology had a poorer survival compared to those with adenocarcinoma or adenocarcinoma with lepidic pattern suptype, with a HR of 1.29.
|
